Moderna, Pfizer and COVID-19

Moderna stock has surged more than 20% this week after regulatory filings showed several executives bought shares on the open ...
As part of a global web of patent litigation over COVID-19 vaccines and mRNA technology, Pfizer and its partner BioNTech ...
Moderna's legal win boosts stock but highlights mRNA technology struggles. Discover why MRNA stock may not sustain long-term ...
The Florida surgeon general in January called for a halt in the use of covid mRNA vaccines. And in Texas, Attorney General ...
HHS is re-evaluating a nearly $600 million contract with Moderna to develop and test vaccines against flu viruses that could ...
Moderna (NASDAQ:MRNA) shares jumped 16% on Wednesday, March 5, following a favorable German court decision that determined ...
Zacks Investment Research on MSN2d
Here's Why Moderna Stock Soared 16% on Wednesday
Shares of Moderna MRNA rose nearly 16% yesterday after a couple of SEC filings showed that two board members bought shares on ...
Now that Novavax has been added to the revamped COVID vaccines, you'll want to make sure to check on the changes to cost and more.